Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Argus Health
Healthtrust
QuintilesIMS
Mallinckrodt
Johnson and Johnson

Generated: September 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,808,468

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,808,468 protect, and when does it expire?

Patent 9,808,468 protects VIVLODEX and is included in one NDA.

This patent has sixteen patent family members in sixteen countries.

Summary for Patent: 9,808,468
Title:Formulation of meloxicam
Abstract: Unit dosage forms of meloxicam containing either 5 mg or 10 mg of meloxicam that provide effective pain relief and have desirable pharmacokinetic properties are described. The unit dosage forms can provide pain relief when a single unit dose is administered to a patient and useful for treating pain such as osteoarthritis pain at a relatively low systemic exposure to meloxicam.
Inventor(s): Bosch; H. William (Bryn Mawr, PA)
Assignee: iCeutica Pty Ltd. (Iluka, WA, AU)
Application Number:15/595,446
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,808,468
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 9,808,468

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Egalet VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 RX Yes No ➤ Sign Up ➤ Sign Up MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 5 MG OF MELOXICAM ➤ Sign Up
Egalet VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 RX Yes No ➤ Sign Up ➤ Sign Up MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 10 MG OF MELOXICAM ➤ Sign Up
Egalet VIVLODEX meloxicam CAPSULE;ORAL 207233-002 Oct 22, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 10 MG OF MELOXICAM ➤ Sign Up
Egalet VIVLODEX meloxicam CAPSULE;ORAL 207233-002 Oct 22, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up MANAGEMENT OF OSTEOARTHRITIS PAIN BY ADMINISTERING 5 MG OF MELOXICAM ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
Accenture
Moodys
Boehringer Ingelheim
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.